CA
NZ
UK
AU
IND
US
Delcath Systems (NASDAQ:DCTH) rose 6.78% on June 23, 2026, closing at $12.29 after a $0.78 per-share move. The session’s advance came as HEPZATO sales outlook sustained commercial momentum, based on the available company disclosures and trading context.
Seres Therapeutics (NASDAQ:MCRB) rose 6.82% on June 23, 2026, closing at $7.05 after a $0.45 per-share move. The session’s advance came as cash runway extension supported the microbiome therapy stock, based on the available company disclosures and trading context.
KALA BIO (NASDAQ:KALA) fell 11.86% on June 23, 2026, closing at $3.12 after a $0.42 per-share move. The session’s decline came as post-split profit taking pressured the ocular biotech, based on the available company disclosures and trading context.
Jade Biosciences (NASDAQ:JBIO) rose 12.96% on June 23, 2026, closing at $21.97 after a $2.52 per-share move. The session’s advance came as lupus programme anticipation drove the clinical-stage biotech, based on the available company disclosures and trading context.
Tenax Therapeutics (NASDAQ:TENX) rose 11.35% on June 23, 2026, closing at $13.64 after a $1.39 per-share move. The session’s advance came as pulmonary hypertension programme attracted biotech demand, based on the available company disclosures and trading context.
Universe Pharmaceuticals (NASDAQ:UPC) rose 6.67% on June 23, 2026, closing at $3.04 after a $0.19 per-share move. The session’s advance came as technical buying lifted the herbal medicine micro-cap, based on the available company disclosures and trading context.
uniQure (NASDAQ:QURE) rose 10.48% on June 23, 2026, closing at $49.04 after a $4.65 per-share move. The session’s advance came as FDA path to AMT-130 filing sustained the Huntington’s rally, based on the available company disclosures and trading context.
Shoulder Innovations (NYSE:SI) rose 8.55% on June 23, 2026, closing at $19.29 after a $1.52 per-share move. The session’s advance came as implant growth expectations pushed shares near a yearly high, based on the available company disclosures and trading context.
Monopar Therapeutics (NASDAQ:MNPR) rose 19.09% on June 23, 2026, closing at $81.77 after a $13.11 per-share move. The session’s advance came as institutional event raised visibility for the rare-disease pipeline, based on the available company disclosures and trading context.
SeaStar Medical (NASDAQ:ICU) rose 7.10% on June 23, 2026, closing at $3.47 after a $0.23 per-share move. The session’s advance came as technical rebound lifted the blood-purification developer, based on the available company disclosures and trading context.
Please wait processing your request...